Ligand Pharmaceuticals Emphasizes Resilience in the Biotech Sector

Ligand Pharmaceuticals is a US biopharma company based in Jupiter (Florida), specializing in a licensing and royalty model: instead of developing drugs to market readiness themselves, it holds stakes and platform technologies such as Captisol®, which are used by large pharmaceutical companies to make active ingredients more stable and effective. In this way, Ligand benefits from revenues from around 90 approved therapies, including treatments for cancer, diabetes, and rare kidney diseases, establishing itself as a reliable niche player with consistent...